At a glance
- Originator Bristol-Myers Squibb
- Class Antivirals
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 13 Jun 2001 No-Development-Reported for HIV infections treatment in USA (Unknown route)
- 06 Aug 1998 New profile
- 15 Jun 1998 Preclinical development for HIV infections treatment in USA (Unknown route)